Agenus reported $2.83M in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agenus AGEN:US $ 2.83M 0.16M
Amgen AMGN:US $ 31343M 96M
AstraZeneca AZN:LN 387M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Celldex Therapeutics CLDX:US $ 0.05M 0M
Chemocentryx CCXI:US $ 0.07M 0M
Dynavax Technologies DVAX:US $ 0.13M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Genocea Biosciences GNCA:US $ 0.06M 0M
GlaxoSmithKline GSK:LN 134700M 0M
Glaxosmithkline GSK:US $ 1347M 0M
Intrexon XON:US $ 0M 0M
Jiangsu Hengrui Me. 600276:CH CH 6.38B 0
Karyopharm Therapeutics KPTI:US $ 8K 0
Macrogenics MGNX:US $ 0.62M 0M
Merck MRK:GR € 565M 0M
Northwest Biotherapeutics NWBO:US 1.03M 64K
Novartis NOVN:VX SF 890M 11M
Novavax NVAX:US $ 0.79M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sangamo Biosciences SGMO:US $ 1.53M 0.07M
Veracyte VCYT:US $ 0.07M 0M
YTE INCY:US $ 0.22M 0M